These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26906711)

  • 1. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.
    Vasikaran SD; Chubb SA
    Endocrine; 2016 May; 52(2):222-5. PubMed ID: 26906711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
    Camacho PM; Lopez NA
    Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
    Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.
    Glendenning P; Chubb SAP; Vasikaran S
    Clin Chim Acta; 2018 Jun; 481():161-170. PubMed ID: 29544749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone turnover markers: use in osteoporosis.
    Naylor K; Eastell R
    Nat Rev Rheumatol; 2012 Jun; 8(7):379-89. PubMed ID: 22664836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biochemical markers in the management of osteoporosis.
    Henriksen K; Christiansen C; Karsdal MA
    Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bone turnover markers in clinical practice.
    Biver E
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):468-73. PubMed ID: 23128576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using early biomarker data to predict long-term bone mineral density: application of semi-mechanistic bone cycle model on denosumab data.
    Zheng J; van Schaick E; Wu LS; Jacqmin P; Perez Ruixo JJ
    J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):333-47. PubMed ID: 26123919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover markers: Emerging tool in the management of osteoporosis.
    Shetty S; Kapoor N; Bondu JD; Thomas N; Paul TV
    Indian J Endocrinol Metab; 2016; 20(6):846-852. PubMed ID: 27867890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Bone Turnover Markers in Clinical Practice for the Management of Osteoporosis in Korea: From the Survey on the Prescription Pattern of Bone Turnover Markers.
    Ahn SH; Park SY; Yoo JI; Chung YJ; Jeon YK; Yoon BH; Kim HY; Lee SH; Lee J; Hong S
    J Bone Metab; 2019 Nov; 26(4):271-277. PubMed ID: 31832393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
    Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R;
    J Bone Miner Res; 2009 Sep; 24(9):1544-51. PubMed ID: 19338427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Lane NE; Saag K; O'Neill TJ; Manion M; Shah R; Klause U; Eastell R
    Osteoporos Int; 2021 May; 32(5):831-840. PubMed ID: 33236195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Bone-Turnover Markers in Asia-Pacific Populations.
    Vasikaran S; Thambiah SC; Tan RZ; Loh TP;
    Ann Lab Med; 2024 Mar; 44(2):126-134. PubMed ID: 37869778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of bone turnover marker concentrations in osteoporosis.
    Morris HA; Eastell R; Jorgensen NR; Cavalier E; Vasikaran S; Chubb SAP; Kanis JA; Cooper C; Makris K;
    Clin Chim Acta; 2017 Apr; 467():34-41. PubMed ID: 27374301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.
    Yoon BH; Yu W
    J Bone Metab; 2018 May; 25(2):73-78. PubMed ID: 29900156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards optimising the provision of laboratory services for bone turnover markers.
    Vasikaran SD; Chubb SA; Schneider HG
    Pathology; 2014 Jun; 46(4):267-73. PubMed ID: 24798169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosis.
    Chubb SA; Mandelt C; Vasikaran S
    Clin Biochem; 2016 May; 49(7-8):529-33. PubMed ID: 26680567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
    Greenblatt MB; Tsai JN; Wein MN
    Clin Chem; 2017 Feb; 63(2):464-474. PubMed ID: 27940448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.